kosutka's News: Nanostring technologies inc.. NanoString Technologies, Inc. (NASDAQ:NASDAQ:NSTG) Q4 2022 Ea

Author-67 Lnpf Phmgtdzbpor
Jul 15th, 2024

Apr 18, 2022 · Dr. Rob Hershberg steps down from Board after seven years of service. SEATTLE-- (BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of Dr. Teresa (Teri) Foy to the Board of Directors, effective April 18, 2022. About NanoString Technologies, Inc. NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers ...SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the third quarter ended September 30, 2023, as well as a reorganization designed to accelerate the Company’s path to profitability.NANOSTRING TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) Three Months Ended. March 31, 2023 2022 Revenue: Instruments $ 11,370 $ 9,103 Consumables 19,776 17,468 Services and other 4,659Nov 15, 2023 · “NanoString is a uniquely innovative place to work, as we get to do far more exciting and cutting-edge science than most companies our size. We experience the thrill of building technologies alongside the satisfaction that comes from participating in research advancing patient care for a broad range of disease areas.” Generated Orders for ~ 50 Spatial Biology Instruments, Representing 65% Growth Year-over-Year, Including Orders for More than 25 CosMx Spatial Molecular Imagers NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended …Defendant: NanoString Technologies, Inc. Case Number: 1:2022cv00261. Filed: February 28, 2022. Court: US District Court for the District of Delaware.PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. TXG, a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of ...Mar 1, 2022 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2021. Phone: 1 888-358-NANO (6266) Fax: 206-378-6288 General Investor Inquiries: [email protected] Biology Definition. Spatial Biology is defined as the study of tissues within their own 2D or 3D context. It is the new frontier of molecular biology. Consider how GPS captures location coordinates …About NanoString Technologies, Inc. NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers ...How It Works. GeoMx DSP empowers you to select distinct tissue compartments or cell types with a resolution down to 10 microns. Using an array of micromirrors, the tissue is exposed to UV light only in those areas selected for masking, including non-contiguous areas. Barcodes are released and quantified downstream.A high-level overview of NanoString Technologies, Inc. (NSTG) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Mar 22, 2021 · About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. Joseph M. Beechem, Ph.D., has served as the chief scientific officer and senior vice president of Research and Development at NanoString since April 2012. Before joining NanoString, Dr. Beechem held various positions at Life Technologies, a publicly traded biotechnology tools company. He most recently served as vice president, head of Advanced ...In a real-world setting, the Prosigna assay reliably identified low risk patients that were either node-negative or had one to three positive nodes, which could help clinicians decide if a patients could safely avoid adjuvant chemotherapy. 3 Extensive global evidence of clinical validity and clinical utility in over 5,200 patients treated with 5 years of standard-of-care …Company Description: NanoString Technologies develops, manufactures and markets technologies that unlock scientifically valuable and clinically actionable information from minute amounts of biological material. The company makes a complex genomic analysis device called the nCounter Analysis System, the device uses tissue extracted from a …About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,300 peer-reviewed publications, offers …About NanoString Technologies, Inc. NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler, cited in approximately 190 peer-reviewed publications, is a flexible and ...“NanoString is a uniquely innovative place to work, as we get to do far more exciting and cutting-edge science than most companies our size. We experience the thrill of building technologies alongside the satisfaction that comes from participating in research advancing patient care for a broad range of disease areas.”In this report, “we,” “our,” “us,” “NanoString,” and “the Company” refer to NanoString Technologies, Inc. and its subsidiaries. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the ...

1.1. Biology and Prognostic Biomarkers in Breast Cancer . In recent years, improvements in diagnostic tools and treatments have led to better outcomes for patients with breast cancer; however, there are still subgroups of patients with aggressive disease where effective therapies remain elusive [1,2].Breast cancer is a heterogenous disease, …About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,200 peer-reviewed publications, offers …A total of 125 ng of RNA from each sample was subjected to PanCancer IO 360 Gene Expression Panel (Catalog No. XT-CSO-IO360-12) using nCounter MAX Analysis System (NanoString Technologies, Inc ...Dec 13, 2022 · NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler, cited in more than 170 peer-reviewed publications, is a flexible and consistent solution combining the power of ... Joseph M. Beechem, Ph.D., has served as the chief scientific officer and senior vice president of Research and Development at NanoString since April 2012. Before joining NanoString, Dr. Beechem held various positions at Life Technologies, a publicly traded biotechnology tools company. He most recently served as vice president, head of Advanced ... Nanostring Technologies Inc (NASDAQ:NSTG) has a beta value of 1.32 and has seen 2.38 million shares traded in the last trading session. The company, currently valued at $26.68M, closed the last trade at $0.55 per share which meant it gained $0.05 on the day or 11.48% during that session. The NSTG stock price is -2300.0% off its 52-week …Jun 30, 2023 · NANOSTRING TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) Three Months Ended. June 30, Six Months Ended. June 30, 2023 2022 2023 2022 Revenue: Instruments $ 17,629 $ 9,538 $ 28,999 NSTG Stock Price | NanoString Technologies Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch NSTG | Complete NanoString Technologies Inc. stock news by …NanoString Technologies, Inc. Jul 2015 - Present 8 years 5 months. Nanostring CMO Cleave Biosciences Feb 2014 - Jun 2015 1 year 5 months. Burlingame ...10x filed a second suit against NanoString in the U.S. District Court for the District of Delaware alleging that NanoString's CosMx Spatial Molecular Imager and associated instruments, reagents ...Plaintiff NanoString Technologies, Inc. (“NanoString” or “Plaintiff”) alleges in its Complaint for patent infringement against Defendant 10x Genomics, Inc. (“10x” or “Defendant”) as follows: NATURE OF THE ACTION 1. This is an action for infringement of U.S. Patent No. 11,473,142 (the “142 Patent”Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively license select nCounter-based diagnostic assets and rights to Veracyte Inc. for $50 million in cash and Veracyte stock, plus up to $10 million in cash ...

schd fund

PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent ...About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,300 peer-reviewed publications.SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced the launch of the Spatial Atlas of Human Anatomy (SAHA) initiative, in collaboration with Weill Cornell Medicine, to create multicellular, single-cell, and sub-cellular maps of 30 non-diseased organs from a healthy and diverse ...Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString. GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents . PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: …Brad Gray, President and CEO, NanoString Technologies, Inc. NanoString also announced today that it was withdrawing its full year 2023 and fourth quarter financial guidance, pending a review of ...NanoString Technologies, Inc. Jul 2015 - Present 8 years 5 months. Nanostring CMO Cleave Biosciences Feb 2014 - Jun 2015 1 year 5 months. Burlingame ...10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies. PR Newswire. PLEASANTON, Calif., Nov. 17, 2023. Jury Awards 10x Genomics Over $31 Million in Damages and Finds ...CosMx™ Custom Solutions. Customize RNA and Protein assays. Add target genes from any species of interest, or any protein target to your already high plex analysis…. One spatial molecular imager, multiple datasets and support programs.About NanoString Technologies, Inc. NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers ...COVID-19 Self Attestation Form Download. We offer CX Labs in both Seattle and Amsterdam. NanoString has office locations around the globe. We continue to broaden our reach with key leaders, sales, service, and support to keep a competitive.President & CEO at NanoString Technologies, Inc. Our mission at NanoString is to map the… | Learn more about Brad Gray's work experience, education, connections & more by visiting their profile ...May 10, 2021 · About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. Our nCounter® Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and ... NanoString Technologies seeks the best and the brightest to join us in our mission to provide innovative tools and technologies to researchers and scientists around the globe. Working at NanoString provides the opportunity to contribute to the discovery and development of new therapies for better patient outcomes. How It Works. GeoMx DSP empowers you to select distinct tissue compartments or cell types with a resolution down to 10 microns. Using an array of micromirrors, the tissue is exposed to UV light only in those areas selected for masking, including non-contiguous areas. Barcodes are released and quantified downstream.Plaintiff NanoString Technologies, Inc. (“NanoString” or “Plaintiff”) alleges in its Complaint for patent infringement against Defendant 10x Genomics, Inc. (“10x” or “Defendant”) as follows: NATURE OF THE ACTION 1. This is an action for infringement of U.S. Patent No. 11,473,142 (the “142 Patent”

Mar 1, 2022 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2021. May 17, 2023 · SEATTLE & MUNICH, May 17, 2023--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today responded to ... COVID-19 VACCINATION REQUIREMENT: NanoString has a COVID-19 vaccination policy that applies to ALL U.S. employees (regardless of work location), onsite contractors and visitors except as ...Feb 2, 2023 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced the launch of the Spatial Atlas of Human Anatomy (SAHA) initiative, in collaboration with Weill Cornell Medicine, to create multicellular, single-cell, and sub-cellular maps of 30 non-diseased organs from a healthy and diverse ... Nov 9, 2023 · NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. Company Description: NanoString Technologies develops, manufactures and markets technologies that unlock scientifically valuable and clinically actionable information from minute amounts of biological material. The company makes a complex genomic analysis device called the nCounter Analysis System, the device uses tissue extracted from a …About NanoString Technologies, Inc. NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company's nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications.Joseph M. Beechem, Ph.D., has served as the chief scientific officer and senior vice president of Research and Development at NanoString since April 2012. Before joining NanoString, Dr. Beechem held various positions at Life Technologies, a publicly traded biotechnology tools company. He most recently served as vice president, head of Advanced ... SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023.The cases are 10x Genomics Inc v. NanoString Technologies Inc, U.S. District Court for the District of Delaware, No. 1:22-cv-00261 and 10x Genomics Inc v. Vizgen Inc, U.S. District Court for the ...About NanoString Technologies, Inc. NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter ® Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 3,300 peer-reviewed …NanoString Technologies, Inc. is a publicly-held biotech company offering discovery and translational research solutions. NanoString's products include the nCounter® Gene Expression System, the ...SEATTLE, October 10, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and ...1.Introduction.NanoString Technologies, Inc., a Delaware corporation (the “Company”), proposes to exchange (the “Exchange Transaction” or the “Transactions”) $215,724,000.00 aggregate principal amount of the Company’s 2.625% Convertible Senior Notes due 2025, CUSIP 63009R AD1 (the “Old Notes”) held by certain existing holders of the Old Notes …Join Our Team. NanoString Technologies seeks the best and the brightest to join us in our mission to provide innovative tools and technologies to researchers and scientists …

Jul 13, 2023 · Investor Contact. Phone: 1 888-358-NANO (6266) Fax: 206!

Apr 12, 2022 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary total product and service revenue of approximately $31 million for the first quarter. NanoString Technologies, Inc. is a provider of life science tools for discovery and translational research. It develops, manufactures, and markets technologies of …Phone: 1 888-358-NANO (6266) Fax: 206-378-6288 General Investor Inquiries: [email protected]

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively license select nCounter-based diagnostic assets and rights to Veracyte Inc. for $50 million in cash and Veracyte stock, plus up to $10 million in cash ...NanoString Technologies, Inc. (NASDAQ:NASDAQ:NSTG) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ETCompany ParticipantsDoug Farrell – Investor...

PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent ...NanoString management is reiterating its guidance for fiscal year 2023 total revenue of between $175 -$185 million. About NanoString Technologies, Inc. NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology.University of Washington. Mar 2017 - Jul 20214 years 5 months. Seattle, Washington. During my PhD in David Baker's lab at the University of Washington, I was trained as both a wet lab scientist ...

Map of tour stops

All Comments (69)

Profile Image 78
Ncvpmr Eyqppvqeru
Commented on Jul 12th, 2024
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023.
Profile Image 29
Pmsftn Dkoygfbdmuq
Commented on Jul 14th, 2024
NanoString Technologies, Inc. | 48,646 followers on LinkedIn. Mapping the universe of biology 🧬 | NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for ...
Profile Image 14
Apssbk Ncgmcpscwxi
Commented on Jul 16th, 2024
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2021. First Quarter Financial Highlights Product and service revenue of $31.4 million, 28% year-over-year growth Instrument revenue of $11.7 million, …
Profile Image 09
Cjrrs Ogswsjz
Commented on Jul 15th, 2024
May. 18, 2023, 12:57 PM. Wednesday, 10x Genomics Inc (NASDAQ:TXG) won an injunction in its patent litigation against NanoString Technologies Inc (NASDAQ:NSTG) and its German subsidiary regarding ...